Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Streck Inc. is navigating 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are spread across 3 distinct examiners and 3 distinct art units. The busiest examiner, GORDON, BRIAN R, is currently managing 1 busiest examiner pending office action.
The 3 pending office actions are assigned to 3 distinct examiners, which indicates a distributed prosecution workload. Since 3 distinct art units are involved, the company's intellectual property is being assessed by multiple specialized groups. The 1 busiest examiner pending action shows that no single examiner has a concentrated influence over the 3 pending office actions. Practitioners must coordinate responses for the 3 pending office actions across the 3 distinct art units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GORDON, BRIAN R | 1 | 65.2% | +18.9% |
| GREENE, CAROLYN LEE | 1 | 65.3% | +47.3% |
| MOSS, NATALIE M | 1 | 30.8% | +17.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17614892 | Detection of Antibiotic Resistance Genes | GREENE, CAROLYN LEE | 84d overdue |
| 16324411 | MOLECULAR REFERENCE CONTROLS | MOSS, NATALIE M | 14d |
| 18020893 | SAMPLE COLLECTION CONTAINERS, PROCESSES AND COLLECTED SAMPLES | GORDON, BRIAN R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17614892 | Detection of Antibiotic Resistance Genes | GREENE, CAROLYN LEE | 84d overdue |
| 16324411 | MOLECULAR REFERENCE CONTROLS | MOSS, NATALIE M | 14d |
| 18020893 | SAMPLE COLLECTION CONTAINERS, PROCESSES AND COLLECTED SAMPLES | GORDON, BRIAN R | — |
| Art Unit | Apps |
|---|---|
| 1797 | 1 |
| 1681 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18020893 | SAMPLE COLLECTION CONTAINERS, PROCESSES AND COLLECTED SAMPLES | GORDON, BRIAN R | 1797 | §102§103§112 | Non-Final OA | — | Pending | Feb 10, 2023 |
| 17614892 | Detection of Antibiotic Resistance Genes | GREENE, CAROLYN LEE | 1681 | §101§103§112DP | Non-Final OA | 84d overdue | Pending | Nov 29, 2021 |
| 16324411 | MOLECULAR REFERENCE CONTROLS | MOSS, NATALIE M | 1653 | §103§112 | Non-Final OA | 14d | Pending | Feb 08, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial